GR3025468T3 - 22-oxacholecalciferol derivative and production thereof. - Google Patents

22-oxacholecalciferol derivative and production thereof.

Info

Publication number
GR3025468T3
GR3025468T3 GR970403118T GR970403118T GR3025468T3 GR 3025468 T3 GR3025468 T3 GR 3025468T3 GR 970403118 T GR970403118 T GR 970403118T GR 970403118 T GR970403118 T GR 970403118T GR 3025468 T3 GR3025468 T3 GR 3025468T3
Authority
GR
Greece
Prior art keywords
production
oxacholecalciferol
same
oxacholecalciferol derivative
derivative
Prior art date
Application number
GR970403118T
Other languages
Greek (el)
English (en)
Inventor
Masahiro Kato
Tetsuhiro Mikami
Kiyoshige Ochi
Hiroyoshi Watanabe
Noboru Kubodera
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of GR3025468T3 publication Critical patent/GR3025468T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
GR970403118T 1991-12-18 1997-11-25 22-oxacholecalciferol derivative and production thereof. GR3025468T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP36105191 1991-12-18
PCT/JP1992/001662 WO1993012083A1 (fr) 1991-12-18 1992-12-18 Derive de 22-oxacholecalciferol et son procede de production

Publications (1)

Publication Number Publication Date
GR3025468T3 true GR3025468T3 (en) 1998-02-27

Family

ID=18471985

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403118T GR3025468T3 (en) 1991-12-18 1997-11-25 22-oxacholecalciferol derivative and production thereof.

Country Status (13)

Country Link
US (1) US5436401A (enExample)
EP (1) EP0619304B1 (enExample)
JP (1) JP3493037B2 (enExample)
KR (1) KR100247214B1 (enExample)
AT (1) ATE157966T1 (enExample)
DE (1) DE69222183T2 (enExample)
DK (1) DK0619304T3 (enExample)
ES (1) ES2107650T3 (enExample)
GR (1) GR3025468T3 (enExample)
HK (1) HK1002729A1 (enExample)
SG (1) SG78265A1 (enExample)
TW (1) TW222621B (enExample)
WO (1) WO1993012083A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3563310D1 (en) * 1985-07-30 1988-07-21 Salzgitter Ind Method and device for the preparation of suspensions with constant indications from basic materials with variable properties
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US6121469A (en) 1993-12-23 2000-09-19 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
EP0764443B1 (en) * 1994-04-19 2002-08-14 Chugai Seiyaku Kabushiki Kaisha Products for the treatment of cachexia associated with tumors
GB9607034D0 (en) * 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
AU4244997A (en) * 1996-09-03 1998-03-26 Chugai Seiyaku Kabushiki Kaisha Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
GB9804861D0 (en) * 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
CN1150973C (zh) 1998-07-03 2004-05-26 中外制药株式会社 光化学反应用紫外线照射装置以及使用它的维生素d衍生物的制备方法
DK1219599T3 (da) * 1999-08-27 2010-05-25 Hiroaki Takayama Vitamin-D-derivater som har substituenter i 2-alfa-position
EP1275643A4 (en) 2000-04-19 2009-06-03 Chugai Pharmaceutical Co Ltd DERIVATIVES OF VITAMIN D
DK1295871T3 (da) 2000-06-15 2011-07-11 Chugai Pharmaceutical Co Ltd Vitamin D-derivater med et 22-oxa- eller 22-thiaatom, en C17-sidekæde substitueret med en syre-, ester- eller amid-gruppe og en 16(17)-dobbeltbinding
WO2002017932A1 (fr) * 2000-08-30 2002-03-07 Chugai Seiyaku Kabushiki Kaisha Preparations d'oct
WO2012122451A2 (en) 2011-03-09 2012-09-13 Teva Pharmaceutical Industries Ltd. Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
CN103508999B (zh) 2013-10-12 2015-05-13 浙江海正药业股份有限公司 马沙骨化醇的合成中间体及其制备方法和用途
CN107286067A (zh) * 2016-04-05 2017-10-24 湖南华腾制药有限公司 一种马沙骨化醇的制备方法
CN114728874B (zh) 2019-11-27 2024-04-26 研成精密化学株式会社 用于制备马沙骨化醇的方法及用于其的中间体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140560A (ja) * 1984-12-12 1986-06-27 Chugai Pharmaceut Co Ltd ２０−オキサ−２１−ノルビタミンｄ３誘導体
JPS61267550A (ja) * 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体
JP3050564B2 (ja) * 1989-12-15 2000-06-12 中外製薬株式会社 新規な２２―オキサビタミンｄ誘導体

Also Published As

Publication number Publication date
SG78265A1 (en) 2001-02-20
DE69222183T2 (de) 1998-01-22
DK0619304T3 (da) 1998-02-16
EP0619304B1 (en) 1997-09-10
EP0619304A4 (en) 1995-03-29
WO1993012083A1 (fr) 1993-06-24
TW222621B (enExample) 1994-04-21
EP0619304A1 (en) 1994-10-12
HK1002729A1 (en) 1998-09-11
US5436401A (en) 1995-07-25
KR940703807A (ko) 1994-12-12
ES2107650T3 (es) 1997-12-01
ATE157966T1 (de) 1997-09-15
DE69222183D1 (de) 1997-10-16
JPH0672994A (ja) 1994-03-15
KR100247214B1 (ko) 2000-03-15
JP3493037B2 (ja) 2004-02-03

Similar Documents

Publication Publication Date Title
GR3025468T3 (en) 22-oxacholecalciferol derivative and production thereof.
ES2186672T3 (es) Procedimiento para la produccion de derivados 13-eter de milbemicinas, e intermedios de los mismos.
EP0370461A3 (en) Chalcone derivatives and process for producing the same
ZA200110520B (en) Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient.
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
HU9503719D0 (en) Piperidine derivatives and process for their production
AU747521C (en) Cycloalkene derivatives, process for producing the same, and use
TW271435B (enExample)
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
DE69109514D1 (de) 4-(4-Alkoxyphenyl)-2-Butylaminderivate und deren Herstellungsverfahren.
HU913062D0 (en) Method for producing benzol, pyridyl and pyridine derivatives and pharmaceutical preparatives containing such compounds
HU910748D0 (en) New substituted amine compounds and process for producing them
EP0543095A3 (en) Method for producing 2-amino-6-halogenopurine and synthesis intermediate therefor
GR3033386T3 (en) Vitamin d derivative and process for producing the same.
GB9121943D0 (en) Organic compounds,processes for their production and their use
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
ES2122337T3 (es) Procedimiento para la produccion de semiesteres de acido sulfurico.
HUT59083A (en) Improved process for producing 4-methyl-sulfonyl-benzoic acid derivatives
DK480389D0 (da) Antitumorstof, fremgangsmaade til dets fremstilling og anticancermiddel indeholdende stoffet
EP0627416A4 (en) PROCESS FOR PRODUCING PROSTAGLANDIN E.
AU3630489A (en) Novel derivatives and processes for the production thereof
DK1142860T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af en fluorholdig aminosyreforbindelse ved anvendelse deraf
HUT40117A (en) New process for preparing benzothiazine-carboxamides
MY105291A (en) Process for preparing uracil derivatives.
AU632856B2 (en) Novel inosine/guanosine derivatives